You are here
This animation explains how a cervical smear test (PAP test) is done. What can you expect? Does it hurt and what is the purpose of a cervical smear?
Cervical screening prevents cancer by detecting abnormalities of the cervix and referring women for potential treatment.
We rely on 50 laboratories across England to report on cervical cytology (sometimes called smear test) samples.
Some laboratories have been having trouble meeting demand and achieving the national target of women receiving their results within 14 days.
Cervical screening provider leads are responsible for the quality and effectiveness of NHS Cervical Screening Programme services provided within an organisation.
Whether NHS, private or standalone, all organisations must have a provider lead in place if they provide one or more NHS services for:
p16 immunohistochemistry is used to evaluate for HPV-associated cervical intraepithelial neoplasia. The diagnostic performance of p16 in HIV infection is unclear.
The relatively high incidence of cervical cancer in women at older ages is a continuing concern in countries with long-established cervical screening. Controversy remains on when and how to cease screening. Existing population-based studies on the effectiveness of cervical screening at older ages have not considered women's screening history. We performed a nationwide cohort study to investigate the incidence of cervical cancer after age 60 years and its association with cervical screening at age 61-65, stratified by screening history at age 51-60.
Exfoliative cytology is the microscopic examination of a shed or desquamated cells from the epithelial surface. Centrifuged liquid-based cytology (CLBC) is a modified technique that is used in the current study.
To compare the efficacy of CLBC with conventional cytology in apparently normal mucosa and histologically proven cases of oral squamous cell carcinoma after staining with Papanicolaou stain.
Insufficient gynecological follow-up and cervical screening has been reported in women with cystic fibrosis (CF). Some of these patients will require a pulmonary transplantation, known to be associated with a higher risk of cervical dysplasia. The aim of this study was to explore the results of cervical screening in adult women with CF, and to report the prevalence of abnormal pap smear tests in this population.
Although guidelines have recommended extended interval cervical screening using concurrent human papillomavirus (HPV) and cytology ("cotesting") for over a decade, little is known about its adoption into routine care.
Last year, after reviewing the evidence, the UK NSC recommended that the HPV test should replace cytology as the first (primary) test in cervical screening.
This will be a major change for the NHS Cervical Screening Programme.
Nurses and doctors carry out cervical screening in primary care. So it’s important that those of us working in primary care understand the reasons for the change and the implications of it.